US Patent 9981930 MAGL inhibitors
Patent 9981930 was granted and assigned to Abide Therapeutics on May, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9981930 MAGL inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
